The Law and Ethics of Genetic Engineering: Microbiological Perspectives

Abstract

Genetic engineering, particularly through the lens of microbiology, represents one of the most transformative scientific advancements of the 21st century. Technologies like CRISPR-Cas9 have moved from theoretical concepts to practical tools at an unprecedented pace, outpacing the development of corresponding legal frameworks and ethical consensus. This review provides a comprehensive analysis of the intersection between law, ethics, and microbial genetic engineering. It begins by outlining the fundamental microbiological techniques that form the basis of the field. It then delves into the core ethical principles—beneficence, non-maleficence, autonomy, and justice—as they apply to microbial applications in medicine, agriculture, and industry. The review subsequently examines the current international and national (primarily U.S. and EU) legal landscapes, highlighting the regulatory gaps and challenges posed by rapid innovation. Finally, it explores specific contentious issues, including biosecurity, biocontainment, intellectual property, and environmental release, offering perspectives on paths toward responsible and equitable governance. The central thesis is that a proactive, adaptable, and internationally coordinated approach is essential to harness the benefits of microbial genetic engineering while mitigating its profound risks.